Board of Directors and Advisors

Board of Directors

M. Gabriela Salvador, MD, MPH
Chief Executive Officer of Maternova, Formerly Americares, Pro Mujer, Grameen.

Meg Wirth, MPA, Founder and President
Chief of Strategy, Maternova

Jerry Weinstein, PhD
Armstrong Global Investments (Finance & Strategy)

Benjamin Kahrl
Board Member with White Ribbon Alliance, Guttmacher Institute, Moving Health, The Trotula Fund, WAJAMAMA, Mireille Mulierum, DAF strategic investor in reproductive health

Constance Mao, MD
Board-certified obstetrician, Associate Professor, Obstetrics, University of Washington, investor and global health expert.

Benjamin Ball, MBA
Board observer, Managing Director, 23 years with Francisco Partners, Board Member with Metaswitch Networks, Mitel, Watchguard, Stanford MBA


Board of Advisors

Roy Birnbaum, JD
Roy is a senior commercial and corporate lawyer with more than 35 years of global and general practice experience, particularly in pharmaceuticals and emerging markets, including a wide variety of corporate, transactional and compliance matters, as well as supporting access initiatives for low income markets, various corporate CSR initiatives and managing internal pro bono programs for ex US lawyers and legal staff. He retired in December 2017 from Merck & Co., Inc. as Counsel, International Legal and Compliance, and previously had similar positions with Pfizer, Inc. and Pharmacia Corporation and its predecessors. Roy holds a J.D. from Harvard Law School and a B.A. from Brandeis University.

Shelley Hossenlopp
Shelley is a point-of-care diagnostic technology expert and Executive with 33 years of global and domestic laboratory and medical device commercialization: sales, distribution, marketing, business development, funding, product management, clinical trials, regulatory, manufacturing and Intellectual Property strategy planning. She is an inventor with two patents as co-inventor with US Army. Advanced experience working with the Department of Defense (DoD) and other US and foreign government, Ministries of Health (MOH) and non-government agencies (NGO's) and Fortune 100, 500 firms.

Greg Martin, PhD
Greg is an executive, entrepreneur, engineer and scientist with over 25 years’ experience taking medical technologies from concept to bedside to commercialization in academic, start-up and corporate environments. He has held leadership roles in multiple medical device companies ranging from start-ups to publicly-traded corporations including Hologic Inc., Hemedex Inc. and Cytec. Greg has a track record of success in executive management, team building, R&D, change/crisis management, product development, product launch, operations, clinical research, regulatory affairs, business development, manufacturing and marketing.

Julia Ma, MBA
Julia has more than 20 years of multinational experience in Financial Management, ERP deployment, Integrated Supply Chain/Supply Chain/Distribution and Business Transformation. She develops strategic financial planning, manages pricing and cost, overseas international tax and multi-currency transactions, and leads IT application development, stakeholder analysis, and international operation transitions. Julia has extensive business experiences in both the US and China. She speaks English and Chinese. Julia has an MBA from Wisconsin International University and a GMP from Harvard Business School.

Michael Putnam, MBA, MPA
Mike is an active startup investor and advisor, with fifteen years of experience in consumer mobile and eCommerce companies. He most recently led consumer marketing for Amwell, a leader in telehealth that delivered six million online doctor visits in 2020 and went public with a $100M co-investment from Google. Previously he led mobile product for TripAdvisor and Rue La La. Mike holds a BS from Stanford, an MBA from the Tuck School of Business at Dartmouth, and an MPA from the Harvard Kennedy School.